Delivery Order SPE2DB24D9222-SPE2DB24FAZGE
Award Date
8/27/24
Potential Completion Date
9/18/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,977.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 500-unit vials of Kcentra, a blood coagulant medication, with a performance period ending on April 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, valued at up to $4,999,999, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,116.07 firm fixed-price delivery order is for the provision of 1,000 unit vials of the pharmaceutical drug Kcentra. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC,...
This federal contract award is a delivery order (SPE2DB25FL0U0) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $28,700.64 firm fixed-price contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra. The award is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $4,943.04 firm fixed-price delivery order covers the supply of Kcentra, a 500-unit vial pharmaceutical product, with a period of performance through April 9, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,041.10 firm fixed-price delivery order is for the supply of Kcentra, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders...
This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of 1,000 unit vials of the medication Kcentra, with a total ceiling value of $58,140.00. The contract is a firm fixed-price delivery order with no set-aside designation, and it has an ultimate completion date of August 22, 2024. DMS Pharmaceutical Group Inc. holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $18,896.64 contract is for the delivery of 1,000 units of the specialized medication Kcentra by January 8, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of Kcentra 1,000 unit vials. The order, valued at $17,312.80, is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,714.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the specialty pharmaceutical product Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,453.44 firm fixed-price delivery order is for the procurement of 1,000 unit vials of the medication Kcentra. The award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the...